Microbot Medical Inc (MBOT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Microbot Medical Inc (MBOT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3386
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Microbot Medical Inc (Microbot), formerly StemCells Inc, a subsidiary of Stem Cell Sciences UK Ltd, is a medical device company that develops pharmaceutical, cell based therapeutics and related tools. The company provides research on products for spinal cord injury, thoracic injury, cervical injury, retinal disorders, dry age-related macular degeneration, neurodegenerative diseases, neuronal ceroid lipofuscinosis, and pelizaeus-merzbacher disease. It offers HuCNS-SC cells, proprietary cell culture products and antibody reagents. Microbot’s products are used in stem cell-based drug discovery and research, among others. The company operates in Switzerland and the US. Microbot is headquartered in Hingham, Massachusetts, the US.

Microbot Medical Inc (MBOT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Microbot Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Microbot Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Microbot Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Microbot Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Microbot Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9
Microbot Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Microbot Medical Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
StemCells Acquires Seminal Neural Stem Cell Patent Portfolio From NeuroSpheres 11
Partnerships 12
StemCells Enters Into Agreement With R Biomedical To Develop Reagents For Human iPS Cell Research 12
Licensing Agreements 13
StemCells Enters Into Licensing Agreement With genOway For Internal Ribosome Entry Site Technology 13
Equity Offering 14
StemCells Files Registration Statement for Rights Offering of Shares for up to USD30 Million 14
StemCells Raises USD8 Million in Public Offering of Shares and Warrants 15
StemCells Completes Exercise of Underwriter’s Over Allotment Option for Public Offering of Shares and Warrants for USD27 Million 17
StemCells Raises USD20 Million in Private Placement of Units 19
StemCells Files Registration Statement For IPO To Raise Up To US$100 Million 21
StemCells Completes Public Offering Of Units For US$18.6 Million 22
StemCells Completes Public Offering Of Shares For US$1.6 Million 23
Acquisition 25
StemCells Acquires Microbot Medical 25
Microbot Medical Inc – Key Competitors 26
Microbot Medical Inc – Key Employees 27
Microbot Medical Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Financial Announcements 29
Aug 14, 2017: Microbot Medical Reports Second Quarter 2017 Financial Results and Recent Development and Strategic Progress 29
May 15, 2017: Microbot Medical Reports First Quarter 2017 Financial Results and Recent Development Progress 30
Corporate Communications 31
Feb 07, 2017: Microbot Medical Strengthens Board of Directors with Medical Device Veteran Martin J. Madden 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Microbot Medical Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Microbot Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Microbot Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Microbot Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Microbot Medical Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Microbot Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9
Microbot Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
StemCells Acquires Seminal Neural Stem Cell Patent Portfolio From NeuroSpheres 11
StemCells Enters Into Agreement With R Biomedical To Develop Reagents For Human iPS Cell Research 12
StemCells Enters Into Licensing Agreement With genOway For Internal Ribosome Entry Site Technology 13
StemCells Files Registration Statement for Rights Offering of Shares for up to USD30 Million 14
StemCells Raises USD8 Million in Public Offering of Shares and Warrants 15
StemCells Completes Exercise of Underwriter's Over Allotment Option for Public Offering of Shares and Warrants for USD27 Million 17
StemCells Raises USD20 Million in Private Placement of Units 19
StemCells Files Registration Statement For IPO To Raise Up To US$100 Million 21
StemCells Completes Public Offering Of Units For US$18.6 Million 22
StemCells Completes Public Offering Of Shares For US$1.6 Million 23
StemCells Acquires Microbot Medical 25
Microbot Medical Inc, Key Competitors 26
Microbot Medical Inc, Key Employees 27
Microbot Medical Inc, Subsidiaries 28

List of Figures
Microbot Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Microbot Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Microbot Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Microbot Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Microbot Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Microbot Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Microbot Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Microbot Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Microbot Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Microbot Medical Inc (MBOT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Insperity, Inc. (NSP):企業の財務・戦略的SWOT分析
    Insperity, Inc. (NSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Azul SA (AZUL4):企業の財務・戦略的SWOT分析
    Azul SA (AZUL4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Kotak Mahindra Bank Ltd (KOTAKBANK):企業の財務・戦略的SWOT分析
    Kotak Mahindra Bank Ltd (KOTAKBANK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • PT Aerowisata:企業の戦略・SWOT・財務分析
    PT Aerowisata - Strategy, SWOT and Corporate Finance Report Summary PT Aerowisata - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Mediclin AG (MED):企業の財務・戦略的SWOT分析
    Summary Mediclin AG (Mediclin) is a healthcare service provider that provides rehabilitation and medical care services. The center provides services in neuro-medicine with neurology, early neurological rehabilitation, neurosurgery and neuroradiology and psychological sciences, among others. It also …
  • AdAlta Ltd (1AD):製薬・医療:M&Aディール及び事業提携情報
    Summary AdAlta Ltd (AdAlta), formerly AdAlta Pty Ltd, is a biotechnology company that discovers and develops new class of protein therapeutics for wide range of human diseases. The company's lead i-body candidate, AD-114, is being developed for the treatment of idiopathic pulmonary fibrosis and othe …
  • Fluor Corporation (FLR)-エネルギー分野:企業M&A・提携分析
    Summary Fluor Corporation (Fluor) is a provider of engineering and construction services. The company's service portfolio includes design, engineering, procurement, fabrication, modularization, construction, commissioning and maintenance, and project management solutions. Fluor also offers other ser …
  • Biolase, Inc. (BIOL)-医療機器分野:企業M&A・提携分析
    Summary Biolase, Inc. (Biolase) is medical device company which develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser s …
  • Targa Resources Partners LP (NGLS PR A):石油・ガス:M&Aディール及び事業提携情報
    Summary Targa Resources Partners LP (Targa Resources) is an independent midstream company. It carries out the gathering, compressing, treating, processing and sale of natural gas, and storing, fractionating, treating, transporting and selling natural gas liquids (NGLs) and NGL products. The company …
  • AS Kevelt-製薬・医療分野:企業M&A・提携分析
    Summary AS Kevelt (Kevelt), a subsidiary of Pharmsynthez is a healthcare company that develops, manufactures and markets drug products. The company offers products which include concentrate solutions for infusion, endocervical gel, eye drops and other solutions. It also offers sub-contracting and di …
  • TenneT Holding BV:企業の戦略的SWOT分析
    TenneT Holding BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Kadaster:企業の戦略的SWOT分析
    Kadaster - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Novartis Pharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析
    Summary Novartis Pharmaceuticals Corp (Novartis), a subsidiary of Novartis AG is a developer, manufacturer and distributor of active ingredients, patent protected medicines and treatments for the healthcare industry. The company’s products include innovative prescription medicine and drugs, tablets, …
  • REV Group Inc (REVG):企業の財務・戦略的SWOT分析
    REV Group Inc (REVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nigerian National Petroleum Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Nigerian National Petroleum Corp (NNPC) is a state-owned vertically integrated oil and gas company, which explores for, produces, markets and distributes crude oil, refined petroleum, petrochemicals and associated by-products. It operates through a network of refineries that produce products …
  • Butler National Corporation:企業の戦略・SWOT・財務情報
    Butler National Corporation - Strategy, SWOT and Corporate Finance Report Summary Butler National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Viracta Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Viracta Therapeutics Inc (Viracta) is a drug development company that develops medicine to address viral associated cancer. The company's kick and kill platform is designed to treat viral associated cancers and other serious diseases. Its product development pipeline includes ebv lymphoma, e …
  • CDI Corp:企業の戦略的SWOT分析
    CDI Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • BioCat GmbH-医療機器分野:企業M&A・提携分析
    Summary BioCat GmbH (BioCat) is a medical device company that markets innovative products and services for life science research. The company provides products such as antibodies, epigenetics, PCR, cloning, viral systems, tissue-specific analysis, reporter assays, diabetes, fluorescent proteins, sam …
  • Abbott Laboratories (ABT):企業の財務・戦略的SWOT分析
    Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆